Publication | Open Access
6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers
46
Citations
28
References
2019
Year
PFKFB2 is a novel target whose inhibition can enhance the effect of paclitaxel-based primary chemotherapy upon ovarian and breast cancers retaining wt<i>TP53</i>.
| Year | Citations | |
|---|---|---|
Page 1
Page 1